成中的认知功能障碍 (CDiA):神经元与邻居之间的协作研究计划的协议
Yuliya S Nikolova1,2,3, Anthony C Ruocco1,2,3,4, Daniel Felsky1,2,5
1Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Frontiers in psychiatry
|June 4, 2025
概括
认知功能障碍,特别是执行功能 (EFs),在物质使用障碍 (SUDs) 中发挥着关键作用. 了解EF的使用方法
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 药物使用障碍 (SUDs) 是一个重大的全球健康挑战.
- 执行职能 (EF) 涉及成机制,但它们在SUD中的作用需要进一步阐明.
- 现有研究在理解EF与神经回路,生物标志物,疾病异质性和功能结果的联系方面存在差距.
研究的目的:
- 引入认知功能障碍在成 (CDiA) 计划中的认知功能障碍,一个整合性研究倡议.
- 调查EF在SUD患者的功能结果中的关键作用.
- 填补知识空白,推动对增强SUD治疗的发现.
主要方法:
- 一个涉及七个项目的跨学科计划,目标样本为400名接受SUD治疗的成年人 (18-60岁).
- 在一年的时间内进行纵向跟踪,以评估SUD,EF (抑制,工作记忆,设置转移),神经回路,生物标志物和功能结果之间的关联.
- 包括临床试验 (重复性横磁刺激),临床前研究,医疗保健利用分析,定性研究和高级数据建模 (集群,深度学习).
主要成果:
- 项目1-3研究了SUD症状,大脑电路,血液生物标志物,EF和功能结果 (残疾,生活质量) 之间的关系.
- 项目4-5评估了影响SUD环境效应的干预措施.
- 项目6将EF与医疗保健使用和治疗参与障碍联系起来.
- 项目7集成了多模式数据,使用先进的计算方法识别患者亚型.
结论:
- 该CDiA计划旨在整合各种科学领域,以了解EF与SUD严重程度和恢复的联系.
- 这些发现将促进新的发现,以改善SUD患者的治疗方法和健康结果.
- 这项研究支持一种整体的,生物心理社会方法来解决成的认知方面.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
447
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
447
CNS Depressants: Alcohol and Nicotine
179
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
179
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
106
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
106
Substance Use Disorders Affecting Sleep
161
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
161
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
167
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
167


